0001140361-21-034427.txt : 20211012 0001140361-21-034427.hdr.sgml : 20211012 20211012194758 ACCESSION NUMBER: 0001140361-21-034427 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20211007 FILED AS OF DATE: 20211012 DATE AS OF CHANGE: 20211012 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Civik Thomas CENTRAL INDEX KEY: 0001723092 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40881 FILM NUMBER: 211319823 MAIL ADDRESS: STREET 1: C/O FOUNDATION MEDICINE, INC. STREET 2: 150 SECOND STREET CITY: CAMBRIDGE STATE: MA ZIP: 02141 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Pyxis Oncology, Inc. CENTRAL INDEX KEY: 0001782223 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 831160910 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 800 BOYLSTON STREET STREET 2: SUITE 1555 CITY: BOSTON STATE: MA ZIP: 02199 BUSINESS PHONE: (617) 351-2575 MAIL ADDRESS: STREET 1: 800 BOYLSTON STREET STREET 2: SUITE 1555 CITY: BOSTON STATE: MA ZIP: 02199 4 1 form4.xml FORM 4 X0306 4 2021-10-07 0001782223 Pyxis Oncology, Inc. PYXS 0001723092 Civik Thomas C/O PYXIS ONCOLOGY, INC. 35 CAMBRIDGEPARK DRIVE CAMBRIDGE MA 02140 true Stock Option (Right to buy) 16 2021-10-07 4 A 0 42191 0 A 2031-10-07 Common Stock 42191 42191 D These stock options vest as to 1/3 of the shares covered by the option on each annual general meeting of the Issuer's stockholders following the October 7, 2021 grant date, subject to the reporting person's continued service through the applicable vesting date. /s/ Pamela Connealy, Attorney-in-Fact for Thomas Civik 2021-10-12